NonSurgical Debridement
Health and Human Services (all) · BARDA - ASPR / DAAPPO / BARDA DCMA
Materiality: 64.3% of $VCEL revenue (High) SEC
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 75A50126C00002 in this department, oldest first.
- Apr 2, 2026 · this noticeAward NoticeVERICEL CORPORATION · $196.9M
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Note the winner and the end of the period of performance for the recompete.
- Follow the agency to see the next notice for this work.
What the notice says
This acquisition will allow BARDA to support procurement of an FDA-approved enzymatic debridement product and support development of a next generation product for increased preparedness value.
Who won similar work
8 award notices on SAM.gov in the last 24 months. Matched by: Same office (BARDA - ASPR / DAAPPO / BARDA DCMA), same NAICS 541714.
Single-winner award sizes (8): middle half $75.8M to $339.6M, median $142.9M; range $84K to $1.0B.
| Winner | Awards | Value | Last |
|---|---|---|---|
| ALBERT B. SABIN VACCINE INSTITUTE, INC. | 1 | $1.0B | May 7, 2026 |
| KALEO, INC. | 1 | $340.9M | Sep 30, 2026 |
| CIDARA THERAPEUTICS INC | 1 | $339.2M | Oct 14, 2025 |
| RAFA LABORATORIES LTD | 1 | $186.0M | Oct 1, 2025 |
| Flosonics Medical LLC | 1 | $99.7M | Jun 5, 2026 |
| OSIVAX Paris 8 �le-de-France 75008 FRA | 1 | $98.6M | Oct 14, 2025 |
| ISOLA THERAPEUTICS INC | 1 | $7.5M | Apr 27, 2026 |
| MEDIMMUNE LLC | 1 | $84K | Mar 17, 2025 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
- Sep 30, 2026KALEO, INC.$340.9MRFP - 2-PAM Autoinjectors for Project Bioshield (PBS)No listed company matched (Materiality N/A)
- Jun 5, 2026Flosonics Medical LLC$99.7MBiomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)No listed company matched (Materiality N/A)
- May 7, 2026ALBERT B. SABIN VACCINE INSTITUTE, INC.$1.0BStrategic Marburg Advanced Research and Development, Preparedness, Registration, Evaluation and Procurement (SMART-PREP)No listed company matched (Materiality N/A)
- Apr 27, 2026ISOLA THERAPEUTICS INC$7.5MBARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)No listed company matched (Materiality N/A)
- Oct 14, 2025OSIVAX Paris 8 �le-de-France 75008 FRA$98.6MClinical Proof of Concept of OVX836, a single-shot broadly protective Influenza A vaccine for immediate protection against emerging pandemic strainsNo listed company matched (Materiality N/A)
- Oct 14, 2025CIDARA THERAPEUTICS INC$339.2MDevelopment of CD388 as a long-lasting prophylactic anti-viral option for protection against the health impacts caused by influenzaNo listed company matched (Materiality N/A)
- Oct 1, 2025RAFA LABORATORIES LTD$186.0MDevelopment Of a Concentrated Tranexamic Acid (TXA) Intramuscular InjectionNo listed company matched (Materiality N/A)
- Mar 17, 2025MEDIMMUNE LLC$84KProcurement of storage and stability services to maintain BARDA�s supply of Live Attenuated Influenza Virus Master and Working Seed LotsNo listed company matched (Materiality N/A)
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 2 of these past winners lobbied Health & Human Services, Dept of (HHS) since 2024 (7 filings)
- 2 of their lobbyists list a past Health & Human Services, Dept of (HHS) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 253 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.